drugset / Trial / NCT03857568

A Trial of SHR0410 Injection in Hemodialysis Participants.

NCT03857568

Phase 1 Completed 8 enrolled Atridia Pty Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a multi-site study to evaluate the safety and pharmacokinetics of repeated doses of IV SHR0410 in participants who are undergoing hemodialysis.

Timeline

Start
2019-04-15
Primary completion
2019-11-08
Completion
2019-11-08

Drugs

EvaluationDrugModalityDoseRoute
Subject SHR0410 Unknown Intravenous

Indications

No indication recorded.